Gamithromycin

(Record date:26/10/2021）

Producers shown on EP

Not showing any

Producer:Shandong Lukang Shelile Pharmaceutical Co., Ltd., established in 1993, is the veterinary drug sector of Lukang medicine. The company has passed ISO9001, ISO14001 and occupational safety and health management system certification at one time. All products have passed the national GMP certification, and some products have passed the FDA certification.

Staff size:1000-1999 people

Registered capital:RMB 255 million 880 thousand

Producer:Established in 2007, Amicogen (China) Biopharm Co., Ltd. （Previous named as Shandong Lukang Record Pharmaceutical Co., Ltd.）is an emerging pharmaceutical company in China. We develop and manufacture API, intermediate and fine chemicals in accordance with related GMP. Our facility is subjected to a strict adherence to environment, health and safely program and has been certificated with ISO9000、ISO14000 and OSHMS.Amicogen (China) has US FDA,Japan PMDA, Europe MRP certification and most products have GMP certification. 

Staff size:600-699 people

Registered capital:RMB 85.3 million

ProducerZhejiang Guobang Pharmaceutical Co., Ltd. is the core enterprise of Guobang enterprise group, mainly producing and operating pharmaceutical raw materials, chemical intermediates and veterinary drugs. The whole enterprise has passed ISO9001:2000 quality system and ISO14001 environmental quality system certification. All products are produced in strict accordance with ICH Q7A standards and have passed the domestic GMP certification. American DMF and European DMF, which have independently compiled drugs, have a production capacity and market share of more than 30% of similar products in China.

Staff size:1000-1999 people

Registered capital:RMB 138.8 million

Producer:Luoyang Huizhong Animal Medicine Co., Ltd., established in 1995, is a wholly-owned subsidiary of Pleco Bioengineering Co., Ltd.

The company's GMP production base has 15 production lines and 3 API production qualifications, and its production capacity ranks in the forefront of the industry.

Registered capital:RMB 50 million

Producer:Hebei Jingzhong Biotechnology Co., Ltd., established in 2010, is a high-tech enterprise specializing in the R & D, production and sales of pharmaceutical raw materials such as tylosin tartrate, tylosin phosphate, tilmicosin tartrate, tylosin tartrate, kitasamycin, gamimamycin, tamoxin fumarate and so on. It is also an early enterprise in China that can produce gamimamycin API.

Staff size:About 50 people

Registered capital:RMB 20 million

Staff size:600-699 people

Registered capital:RMB 50 million